Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 92, Number 5, 1 May 2017

Erythroferrone and matriptase‐2 independently regulate hepcidin expression
pp. E61-E63(3)
Authors: Aschemeyer, Sharraya; Gabayan, Victoria; Ganz, Tomas; Nemeth, Elizabeta; Kautz, Léon

Favourites:
ADD

Identification of targeted therapies for rare adult mature T‐cell leukemia using functional ex vivo screening of primary patient samples
pp. E64-E66(3)
Authors: Borate, Uma; Norris, Brianna A.; Lo, Pierrette; Tognon, Cristina; Tyner, Jeffrey; Spurgeon, Stephen

Favourites:
ADD

Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia
pp. E66-E68(3)
Authors: Ustun, Celalettin; Williams, Sarah; Skendzel, Sasha; Kodal, Behiye; Arock, Michel; Gotlib, Jason; Vallera, Daniel A.; Cooley, Sarah; Felices, Martin; Weisdorf, Daniel; Miller, Jeffrey

Favourites:
ADD

Hematologic malignancies in thalassemia: Adding new cases to the repertoire
pp. E68-E70(3)
Authors: Halawi, Racha; Beydoun, Hassan; Cappellini, M. Domenica; Ferla, Valeria; Taher, Ali

Favourites:
ADD

Genetic modulation of fetal hemoglobin in hydroxyurea‐treated sickle cell anemia
pp. E70-E72(3)
Authors: Aleluia, Milena Magalhães; Santiago, Rayra Pereira; da Guarda, Caroline Conceição; Fonseca, Teresa Cristina Cardoso; Neves, Fábia Idalina; Quinto, Regiana Souza; Figueiredo, Camylla Villas Boas; Yahouédéhou, Sètondji Cocou Modeste Alexandre; Oliveira, Rodrigo Mota; Ferreira, Júnia Raquel Dutra; Cerqueira, Bruno Antônio Veloso; Barbosa, Cynara Gomes; Milton, Jacqueline Nicole; Steinberg, Martin H.; de Souza Gonçalves, Marilda

Favourites:
ADD

Concomitant monitoring of WT1 and FLT3‐ITD expression in FLT3‐ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker?
pp. E72-E74(3)
Authors: De Marchi, Federico; Candoni, Anna; Zannier, Maria Elena; Haley, Lisa; Lau, Bonnie Wing Yin; Fanin, Renato

Favourites:
ADD

Varicella‐zoster virus meningoencephalitis in a patient treated with ruxolitinib
pp. E74-E75(2)
Authors: Eyal, Ophir; Flaschner, Maayan; Ben Yehuda, Arie; Rund, Deborah

Favourites:
ADD

Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm
pp. E75-E77(3)
Authors: Ulrickson, Matthew L.; Puri, Akshjot; Lindstrom, Sarah; Cassaday, Ryan D.; De Padova, Nicolas; Becker, Pamela S.

Favourites:
ADD

Autoimmune hemolytic anemia in a young man with acute hepatitis E infection
pp. E77-E79(3)
Authors: Leaf, Rebecca Karp; O'Brien, Kerry L.; Leaf, David E.; Drews, Reed E.

Favourites:
ADD

Evaluation of the efficiency of hydroxychloroquine in treating children with immune thrombocytopenia (ITP)
pp. E79-E81(3)
Authors: Roche, Ombeline; Aladjidi, Nathalie; Rakotonjanahary, Josué; Leverger, Guy; Leblanc, Thierry; Thomas, Caroline; Pasquet, Marlène; Courcoux, Mary‐France; Bayart, Sophie; Gilibert‐Yvert, Marion; Neven, Bénédicte; Quartier, Pierre; Pellier, Isabelle

Favourites:
ADD

Publication outcomes of abstracts from the American Society of Hematology Annual Meeting
pp. E81-E83(3)
Authors: Baddam, Sujatha; Cutter, Gary R.; Wolfson, Julie A.; Friedman, Gregory K.; Lebensburger, Jeffrey D.

Favourites:
ADD

Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later
pp. 411-413(3)
Authors: Angelucci, Emanuele; Pilo, Federica; Coates, Thomas D.

Favourites:
ADD

A higher prevalence of hematologic malignancies in patients with thalassemia: Background and culprits
pp. 414-416(3)
Authors: Halawi, Racha; Cappellini, Maria D.; Taher, Ali

Favourites:
ADD

Diagnostic impact of the 2016 revised who criteria for polycythemia vera
pp. 417-419(3)
Authors: Barbui, Tiziano; Thiele, Juergen; Gisslinger, Heinz; Carobbio, Alessandra; Vannucchi, Alessandro M.; Tefferi, Ayalew

Favourites:
ADD

New film‐coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower‐risk MDS: Results of the randomized, phase II ECLIPSE study
pp. 420-428(9)
Authors: Taher, Ali T.; Origa, Raffaella; Perrotta, Silverio; Kourakli, Alexandra; Ruffo, Giovan Battista; Kattamis, Antonis; Goh, Ai‐Sim; Cortoos, Annelore; Huang, Vicky; Weill, Marine; Merino Herranz, Raquel; Porter, John B.

Favourites:
ADD

Validation of the acute leukemia‐EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi‐center GITMO cohort
pp. 429-434(6)
Authors: Shouval, Roni; Bonifazi, Francesca; Fein, Joshua; Boschini, Cristina; Oldani, Elena; Labopin, Myriam; Raimondi, Roberto; Sacchi, Nicoletta; Dabash, Osamah; Unger, Ron; Mohty, Mohamad; Rambaldi, Alessandro; Nagler, Arnon

Favourites:
ADD

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis
pp. 435-440(6)
Authors: Warsame, Rahma; Kumar, Shaji K.; Gertz, Morie A.; Lacy, Martha Q.; Buadi, Francis K.; Hayman, Suzanne R.; Leung, Nelson; Dingli, David; Lust, John A.; Lin, Yi; Russell, Stephen; Kapoor, Prashant; Go, Ronald S.; Kourelis, Taxiarchis; Gonsalves, Wilson; Zeldenrust, Steven R.; Kyle, Robert A.; Vincent Rajkumar, S.; Zemla, Tyler; Sloan, Jeffrey; Dispenzieri, Angela

Favourites:
ADD

Prognostic significance of cytogenetic abnormalities in T‐cell prolymphocytic leukemia
pp. 441-447(7)
Authors: Hu, Zhihong; Medeiros, L. Jeffrey; Fang, Lianghua; Sun, Yi; Tang, Zhenya; Tang, Guilin; Sun, Tsieh; Quesada, Andres E.; Hu, Shimin; Wang, Sa A.; Pei, Lin; Lu, Xinyan

Favourites:
ADD

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma
pp. 448-453(6)
Authors: Bennani, N. Nora; LaPlant, Betsy R.; Ansell, Stephen M.; Habermann, Thomas. M.; Inwards, David J.; Micallef, Ivana N.; Johnston, Patrick B.; Porrata, Luis F.; Colgan, Joseph P.; Markovic, Svetomir N.; Nowakowski, Grzegorz S.; Macon, William R.; Reeder, Craig B.; Mikhael, Joseph R.; Northfelt, Donald W.; Ghobrial, Irene M.; Witzig, Thomas E.

Favourites:
ADD

The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia
pp. 454-459(6)
Authors: Mudireddy, Mythri; Barraco, Daniela; Hanson, Curtis A.; Pardanani, Animesh; Gangat, Naseema; Tefferi, Ayalew

Favourites:
ADD

A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma
pp. 460-466(7)
Authors: Berenson, James; Manges, Robert; Badarinath, Suprith; Cartmell, Alan; McIntyre, Kristi; Lyons, Roger; Harb, Wael; Mohamed, Hesham; Nourbakhsh, Ali; Rifkin, Robert

Favourites:
ADD

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy
pp. 467-472(6)
Authors: Rosenthal, Allison; Dueck, Amylou C.; Ansell, Stephen; Gano, Katherine; Conley, Christopher; Nowakowski, Grzegorz S.; Camoriano, John; Leis, Jose F.; Mikhael, Joseph R.; Keith Stewart, A.; Inwards, David; Dingli, David; Kumar, Shaji; Noel, Pierre; Gertz, Morie; Porrata, Luis; Russell, Stephen; Colgan, Joseph; Fonseca, Rafael; Habermann, Thomas M.; Kapoor, Prashant; Buadi, Francis; Leung, Nelson; Tiedemann, Rodger; Witzig, Thomas E.; Reeder, Craig

Favourites:
ADD

Howell–Jolly bodies in acute hemolytic anemia
pp. 473-473(1)
Author: Bain, Barbara J.

Favourites:
ADD

A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum
pp. 474-477(4)
Authors: Reading, N. Scott; Ruiz‐Bonilla, José A.; Christensen, Robert D.; Cáceres‐Perkins, William; Prchal, Josef T.

Favourites:
ADD

Synchronous presentation of intra‐nodal follicular dendritic cell sarcoma and Castleman disease
pp. 478-479(2)
Authors: Jain, Preetesh; Prieto, Victor G.; Manning, John T.; Fowler, Nathan; Medeiros, L. Jeffrey; Kanagal‐Shamanna, Rashmi

Favourites:
ADD

K. pneumoniae liver abscess following deferoxamine subcutaneous self‐injection
pp. 480-481(2)
Authors: Furlan, Ludovico; Graziadei, Giovanna; Colombo, Giulia; Forzenigo, Laura Virginia; Solbiati, Monica

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more